Katrina's Aftermath: The story unfold

Our blogs about
America's Wars
War on Iraq
War on Drugs
War on Afghanistan
War on Columbia
War on Philippines
War on Venezuela

More
Matrix Masters
Blogs
World Events
US News
Science & Health
Earth News
Free Speech
News from Africa
News from Palestine
Bill of Rights Under Attack


Matrix Masters'
SUPPORTERS


Lorenzo's
Random Musings

. . . about Chaos,
Reason, and Hope

         Drug War Archives    War on Drugs [Home]
 
Marijuana Compound Spurs Brain Cell Growth
(Alan Mozes, Forbes, October 13, 2005)
When it comes to the controversy surrounding medical marijuana, an international team of researchers is busy stirring the pot by releasing findings that suggest the drug helps promote brain cell growth while treating mood disorders. . . . According to the study in rats, a super-potent synthetic version of the cannabinoid compound found in marijuana can reduce depression and anxiety when taken over an extended period of time. . . . This mood boost seems to be the result of the drug's ability to promote the growth of new brain cells, something no other addictive drug appears able to do, the researchers say. . . . [COMMENT by Lorenzo: I STRONGLY reject the use of the word "addictive" in relation to cannabis. To begin with, the reporter should study Jonathan Ott's work on addiction, and he will find that it is not possible to become "addicted" to cannabis.] . . . The new findings come on the heels of a U.S. Supreme Court ruling in June granting federal authorities the power to stop doctors from prescribing marijuana. That decision also bars individuals from cultivating the herb for medical purposes. . . . The decision overrides laws currently on the books in 11 states which had legalized the use of marijuana for patients receiving a doctor's approval. According to the ruling, the Supreme Court justices made their decision on the basis of interstate commerce regulations rather than on an evaluation of the pros and cons of medical marijuana use. . . . But does medical marijuana work? To help settle that question, Zhang's team focused on the potential of a synthetic laboratory-produced form of the cannabinoid compound naturally found in the marijuana plant. . . . Humans and other animals also naturally produce the compound, and are known to have cannabinoid receptors lying on the surface of cells in the nervous system and the immune system. . . . Prior research has shown that, when exposed to cannabinoids, these receptors can provoke an anti-inflammatory and anti-convulsive response. They can also instigate a range of psychotropic effects such as euphoria. . . . Autopsies revealed that by the end of the 10-day HU210 treatment regimen, new neurons had been generated and integrated into the circuitry of the hippocampus region of the rat's brains. This process, known as neurogenesis, was still in evidence a full month after treatment had been initiated. . . . Neurogenesis was not triggered in response to brain cells being killed through cannabinoid exposure, the researchers add. In fact, HU210 injections did not appear to prompt any loss of neurons in the hippocampus. . . . Cannabinoid use appeared to boost mood, as well: [COMMENT by Lorenzo: Duh. I could have told them that. Maybe I should get a research grant and study this myself. :-)] According to the scientists, behavioral tests suggest that long-term treatment reduced the rodent's anxiety- and depression-linked behaviors. . . . marijuana alone appears able to promote neurogenesis when used over time and in the right dosage, the researchers say. . . . "If our results can be confirmed in humans, we should anticipate the chronic use of marijuana as a medical treatment for anxiety and depression," Zhang said. . . . Dr. Perry G. Fine, a professor of anesthesiology at the University of Utah School of Medicine Pain Research Center, said more than enough data has already been gathered to confirm medical marijuana's potential benefits. . . . "It's great that there's new science, but to me this is no longer an epiphany," he said. "It's just proving what's been long-suspected. We're behind the curve with the cannabinoids largely because of the stigma of marijuana going years and years back." . . . "I think most people with clinical expertise in the area of palliative medicine know that if patients had access to all the tools we currently have, we could certainly do a whole lot better to help people live with multiple chronic diseases," he added. "The social policies are way behind our technology, and that's where we need some catching up."



posted by LoZo 8:21 AM


Google
This site Web

This page is powered by Blogger. Isn't yours? Weblog Commenting by HaloScan.com

Creative Commons License
This work is licensed under a Creative Commons License.
Copyright © 2000 - 2005 by Lawrence Hagerty
Copyrights on material published on this website remain the property of their respective owners.

News    Palenque Norte     Changing Ages    Passionate Causes    dotNeters    Random Musings    Our Amazon Store    About Us